What is Glomerulonephritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Glomerulonephritis: Definition, Classification, and Management

Glomerulonephritis is a heterogeneous group of disorders characterized by inflammation of the glomeruli (kidney filtration units), presenting with variable combinations of hematuria, proteinuria, hypertension, and reduced kidney function. 1

Classification of Glomerulonephritis

Glomerulonephritis can be classified based on immunopathogenesis into five main categories:

  • Immune-complex mediated glomerulonephritis: Including infection-related glomerulonephritis, IgA nephropathy, lupus nephritis, and cryoglobulinemic glomerulonephritis 1
  • Anti-neutrophil cytoplasmic antibodies (ANCA)-associated (pauci-immune) glomerulonephritis 1
  • Anti-glomerular basement membrane (anti-GBM) glomerulonephritis 2
  • C3 glomerulopathy: Characterized by dominant C3 deposits with minimal or no immunoglobulin deposits 2
  • Monoclonal immunoglobulin-associated glomerulonephritis: Including various forms of monoclonal gammopathy of renal significance (MGRS) 3

Clinical Presentation

Glomerulonephritis can present with:

  • Nephritic syndrome: Characterized by hematuria, edema, hypertension, and variable degrees of renal impairment 4
  • Rapidly progressive glomerulonephritis: Rapid decline in renal function over days to weeks 1
  • Asymptomatic hematuria and proteinuria: Most common presentation 1
  • Disease flares: Particularly common in IgA nephropathy and C3 glomerulopathy 1

Pathophysiology

The underlying mechanisms of glomerulonephritis vary by type:

  • Post-streptococcal glomerulonephritis: Immune complex deposition following streptococcal infection causes inflammation and kidney damage 5
  • ANCA-associated vasculitis: Autoantibodies target neutrophil components, leading to neutrophil activation and vascular damage 2
  • Anti-GBM disease: Autoantibodies target the glomerular basement membrane, causing linear IgG deposits 2
  • Monoclonal gammopathy-related glomerulonephritis: Deposition of monoclonal immunoglobulins in various renal compartments 3

Specific Types of Glomerulonephritis

Infection-Related Glomerulonephritis

  • Post-streptococcal glomerulonephritis: Follows streptococcal infection, with immune complex deposition in glomerular tissue 5
  • Cryoglobulinemic glomerulonephritis: Often associated with HCV infection, characterized by cryoglobulin deposition 3

Monoclonal Gammopathy-Related Glomerulonephritis

  • Monoclonal immunoglobulin deposition disease (MIDD): Affects all renal compartments with non-organized deposits 3
  • Immunoglobulin-related amyloidosis: Characterized by fibrillar deposits that stain with Congo red 3
  • Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID): Deposits confined to glomeruli 3
  • Cryoglobulinemic glomerulonephritis: Features microtubular immunoglobulin deposits 3

Other Important Types

  • IgA Nephropathy: Characterized by mesangial IgA deposits 2
  • Lupus Nephritis: Glomerular involvement in systemic lupus erythematosus 2
  • C3 Glomerulopathy: Includes dense deposit disease and C3 GN 2

Diagnostic Approach

  • Kidney biopsy: Gold standard for diagnosis, providing information on:

    • Pattern of injury
    • Immunofluorescence findings
    • Electron microscopy findings 2, 1
  • Serological testing:

    • Anti-GBM antibodies
    • ANCA
    • Anti-nuclear antibodies
    • Complement levels
    • Specific autoantibodies 2
  • Urinalysis: Evaluation for hematuria, proteinuria, and urinary sediment 4

Treatment Principles

Treatment approaches vary by specific glomerular disease:

  • Post-streptococcal glomerulonephritis:

    • Antibiotics to eliminate streptococcal infection
    • Supportive care including diuretics and antihypertensives
    • Corticosteroids reserved for severe crescentic glomerulonephritis 5
  • Cryoglobulinemic nephritis:

    • For diffuse membranoproliferative glomerulonephritis: Immunomodulating treatment including glucocorticoids, immunosuppressive agents, and plasma exchange
    • For mesangial glomerulonephritis: Direct-acting antiviral therapy as first-line approach 3
  • Monoclonal gammopathy-related glomerulonephritis:

    • Treatment directed at the underlying B-cell or plasma cell clone 3

Prognostic Factors

  • Poor prognostic indicators:

    • Presence of crescents
    • Severe interstitial fibrosis and tubular atrophy
    • High-grade proteinuria
    • Creatinine value >1.5 mg/dL at the time of renal biopsy 3, 2
  • Leading cause of death: Cardiovascular disease (over 60% of cases) 3

Common Pitfalls and Caveats

  • Misdiagnosis: Some cases of monoclonal gammopathy with findings consistent with C3 glomerulonephritis may actually have membranoproliferative glomerulonephritis with masked monoclonal deposits, requiring additional immunofluorescence studies on protease-digested, paraffin-embedded tissue 3

  • Undertreatment: Failure to recognize rapidly progressive forms can lead to irreversible kidney damage 1

  • Overtreatment: Mesangial glomerulonephritis in cryoglobulinemic nephritis may be self-limiting and respond to antiviral therapy alone without requiring aggressive immunosuppression 3

References

Research

Acute glomerulonephritis.

Lancet (London, England), 2022

Guideline

Glomerular Syndromes Classification and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Glomerulonephritis.

Pediatrics in review, 2023

Guideline

Primary Pathophysiology of Post-Streptococcal Glomerulonephritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.